WO1998026286A3 - Sandwich assays for collagen type i fragments - Google Patents

Sandwich assays for collagen type i fragments Download PDF

Info

Publication number
WO1998026286A3
WO1998026286A3 PCT/EP1997/006803 EP9706803W WO9826286A3 WO 1998026286 A3 WO1998026286 A3 WO 1998026286A3 EP 9706803 W EP9706803 W EP 9706803W WO 9826286 A3 WO9826286 A3 WO 9826286A3
Authority
WO
WIPO (PCT)
Prior art keywords
fragments
sandwich assays
collagen type
antibody
sandwich
Prior art date
Application number
PCT/EP1997/006803
Other languages
French (fr)
Other versions
WO1998026286A2 (en
Inventor
Christian Rosenquist
Per Qvist
Original Assignee
Osteometer Biotech As
Christian Rosenquist
Per Qvist
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9625559.1A external-priority patent/GB9625559D0/en
Priority claimed from GBGB9705687.3A external-priority patent/GB9705687D0/en
Application filed by Osteometer Biotech As, Christian Rosenquist, Per Qvist filed Critical Osteometer Biotech As
Priority to DE69705423T priority Critical patent/DE69705423T2/en
Priority to AU57542/98A priority patent/AU5754298A/en
Priority to JP52618698A priority patent/JP3913787B2/en
Priority to EP97953745A priority patent/EP0944833B1/en
Priority to AT97953745T priority patent/ATE202632T1/en
Priority to US09/319,539 priority patent/US6660481B2/en
Publication of WO1998026286A2 publication Critical patent/WO1998026286A2/en
Publication of WO1998026286A3 publication Critical patent/WO1998026286A3/en
Priority to US10/730,070 priority patent/US7195883B2/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/108Osteoporosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds

Abstract

Sandwich assays for collagen degradation products are conducted using an antibody of the same specificity on both sides of the sandwich or using a first antibody reactive with an epitope contained in the sequence Glu-Lys-ala-his-asp-gly-gly-arg (EKAHDGGR) and a second antibody which may be the same or different.
PCT/EP1997/006803 1996-12-09 1997-12-05 Sandwich assays for collagen type i fragments WO1998026286A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
DE69705423T DE69705423T2 (en) 1996-12-09 1997-12-05 SANDWEIGHT TEST FOR DETECTING COLLAGEN FRAGMENTS
AU57542/98A AU5754298A (en) 1996-12-09 1997-12-05 Sandwich assays for collagen type i fragments
JP52618698A JP3913787B2 (en) 1996-12-09 1997-12-05 Method for sandwich measurement of type I collagen fragments
EP97953745A EP0944833B1 (en) 1996-12-09 1997-12-05 Sandwich assays for collagen fragments
AT97953745T ATE202632T1 (en) 1996-12-09 1997-12-05 SANDWIGHT TEST FOR DETECTING COLLAGEN FRAGMENTS
US09/319,539 US6660481B2 (en) 1996-12-09 1997-12-05 Sandwich assays for collagen type I fragments
US10/730,070 US7195883B2 (en) 1996-12-09 2003-12-09 Sandwich assays for collagen fragments

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9625559.1 1996-12-09
GBGB9625559.1A GB9625559D0 (en) 1996-12-09 1996-12-09 Sandwish assays for collagen type I fragments
GBGB9705687.3A GB9705687D0 (en) 1997-03-19 1997-03-19 Sandwich assays for collagen type i fragments
GB9705687.3 1997-03-19

Related Child Applications (3)

Application Number Title Priority Date Filing Date
US09319539 A-371-Of-International 1997-12-05
US09/319,539 A-371-Of-International US6660481B2 (en) 1996-12-09 1997-12-05 Sandwich assays for collagen type I fragments
US10/730,070 Continuation-In-Part US7195883B2 (en) 1996-12-09 2003-12-09 Sandwich assays for collagen fragments

Publications (2)

Publication Number Publication Date
WO1998026286A2 WO1998026286A2 (en) 1998-06-18
WO1998026286A3 true WO1998026286A3 (en) 1998-08-13

Family

ID=26310589

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/006803 WO1998026286A2 (en) 1996-12-09 1997-12-05 Sandwich assays for collagen type i fragments

Country Status (8)

Country Link
US (2) US6660481B2 (en)
EP (1) EP0944833B1 (en)
JP (1) JP3913787B2 (en)
AT (1) ATE202632T1 (en)
AU (1) AU5754298A (en)
DE (1) DE69705423T2 (en)
ES (1) ES2160985T3 (en)
WO (1) WO1998026286A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962639A (en) * 1987-11-06 1999-10-05 Washington Research Foundation Synthetic peptides corresponding to telopeptide sequences of cross-linked type I collagen metabolites
ATE202632T1 (en) * 1996-12-09 2001-07-15 Osteometer Biotech As SANDWIGHT TEST FOR DETECTING COLLAGEN FRAGMENTS
US7354723B2 (en) 1999-11-26 2008-04-08 Nordic Bioscience Dagnostics A/S Assay of isomerised and/or optically inverted proteins and protein fragments
GB9928052D0 (en) * 1999-11-26 2000-01-26 Osteometer Biotech As Assay of isomerised and/or optically inverted proteins and protein fragments
AU2001276395A1 (en) * 2000-07-12 2002-02-05 Werner Naser Direct assessment of relative concentrations of variants of an epitope on a dimeric molecule
JP4365216B2 (en) * 2001-11-01 2009-11-18 レンセレアー ポリテクニック インスティテュート Biocatalytic sol-gel microarray
US20050124071A1 (en) * 2003-09-30 2005-06-09 Kraus Virginia B. Methods and compositions for diagnosing musculoskeletal, arthritic and joint disorders by biomarker dating
EP1943330A4 (en) * 2005-11-01 2009-12-09 Rensselaer Polytech Inst Three-dimensional cellular array chip and platform for toxicology assays
WO2009038771A2 (en) * 2007-09-19 2009-03-26 Massachusetts Institute Of Technology Tolperisone and tolperisone-like drugs for the treatment of k-ras associated cancers
EP2223112A2 (en) * 2007-12-21 2010-09-01 Siemens Healthcare Diagnostics Inc. Circulating epha2 receptor
US8796184B2 (en) 2008-03-28 2014-08-05 Sentilus, Inc. Detection assay devices and methods of making and using the same
USRE49477E1 (en) 2012-04-20 2023-03-28 Thomas Jefferson University Engineered antibody for inhibition of fibrosis
US9753030B2 (en) * 2013-03-06 2017-09-05 University of Pittsburgh—of the Commonwealth System of Higher Education Degradable carbon nanotube-containing biosensors and methods for target clinical marker detection
ES2687220B1 (en) * 2017-03-23 2019-08-08 Servicio Andaluz De Salud Method of obtaining useful data for the screening and diagnosis of osteoporosis
EP4317172A1 (en) * 2021-03-24 2024-02-07 Sekisui Medical Co., Ltd. Immunological analysis method for type-i collagen c-terminal telopeptide
WO2023068249A1 (en) * 2021-10-20 2023-04-27 積水メディカル株式会社 Measuring reagent for cross-linked n-telopeptide of type i collagen, preparation method thereof, and immunoassay method using same

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014844A1 (en) * 1992-12-28 1994-07-07 Baylink David J Bone resorption assay
WO1995008115A1 (en) * 1993-09-17 1995-03-23 Osteometer Biotech As A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
WO1996012193A1 (en) * 1994-10-17 1996-04-25 Osteometer Bio Tech A/S Estimation of the fragmentation pattern of collagen in body fluids and the diagnosis of disorders associated with the metabolism of collagen
EP0718309A1 (en) * 1994-12-23 1996-06-26 Roche Diagnostics GmbH Antigens and antibodies for the detection of collagen I
WO1996030765A1 (en) * 1995-03-24 1996-10-03 Osteometer Biotech A/S Assaying protein fragments in body fluids
WO1996036645A1 (en) * 1995-05-19 1996-11-21 Washington Research Foundation Synthetic peptide analogs of cross-linked n-telopeptides of type i collagen
WO1998008098A2 (en) * 1996-08-22 1998-02-26 Osteometer Biotech A/S Assaying d-amino acids in body fluids
EP0829724A1 (en) * 1996-09-17 1998-03-18 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Assay for detecting collagen degradation

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6716836A (en) 1967-12-11 1969-06-13
DE2816841A1 (en) 1978-04-18 1979-10-31 Max Planck Gesellschaft RADIOIMMUNOLOGICAL DETERMINATION OF PROCOLLAGEN (TYPE III) AND PROCOLLAGEN PEPTIDE (TYPE III)
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
DE3209149A1 (en) 1982-03-13 1983-10-06 Hoechst Ag METHOD FOR THE COMMON IMMUNOLOGICAL DETERMINATION OF PROCOLLAGEN PEPTIDE (TYPE III) AND PROCOLLAGEN PEPTIDE COL 1 (TYPE III) AND METHOD FOR THE PRODUCTION OF ANTI-PROCOLLAGEN PEPTIDE COL 1 (TYPE III) SERUM
US4628027A (en) 1982-05-19 1986-12-09 Molecular Engineering Associates, Ltd. Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
CA1251729A (en) 1982-05-19 1989-03-28 Steffen Gay In vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
SE8304836D0 (en) 1983-09-09 1983-09-09 Pharmacia Ab SETTLE TO DETERMINE CHANGES IN LEDS
US5001225A (en) 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
JPS63209318A (en) 1987-02-26 1988-08-30 Sony Corp Receiver
DE3714634A1 (en) 1987-05-02 1988-11-17 Hoechst Ag METHOD FOR SELECTIVE IMMUNOLOGICAL DETERMINATION OF INTACT PROCOLLAGEN PEPTIDE (TYPE III) AND PROCOLLAGEN (TYPE III) IN BODY LIQUIDS AND MEANS TO IMPLEMENT IT
US5679583A (en) 1987-05-02 1997-10-21 Hoechst Aktiengesellschaft Monoclonal antibodies for the selective immunological determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids
GB2205643B (en) 1987-05-08 1991-03-13 Farmos Group Limited Type iii collagen degradation assay
US5320970A (en) 1987-11-06 1994-06-14 Washington Research Foundation Detection of collagen degradation in vivo
US4973666A (en) 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
US5300434A (en) 1987-11-06 1994-04-05 Washington Research Foundation Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide
DE58908787D1 (en) 1988-04-27 1995-02-02 Hoechst Ag Monoclonal antibody for the selective immunological determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids.
GB8815174D0 (en) 1988-06-25 1988-08-03 Rowett Research Inst Method of monitoring collagen degradation
WO1990004417A1 (en) 1988-10-24 1990-05-03 Bruce Caterson Methods of and compositions for diagnosing, monitoring and treating the early stages of osteoarthritis
WO1990008195A1 (en) 1989-01-13 1990-07-26 President And Fellows Of Harvard College Monoclonal antibody to human type ix collagen
ZA909755B (en) 1989-12-07 1991-09-25 Res Dev Foundation Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product
GB9014220D0 (en) 1990-06-26 1990-08-15 Farmos Yhtymy Oy Method for the immunlolgical determinition of the carboxyterminal propeptide of type i procollagen
GB9105893D0 (en) 1991-03-20 1991-05-08 Orion Yhtymae Oy Bone resorption assay based on a peptide liberated during collagen degradation
DE4225038C2 (en) 1992-07-29 1995-11-30 Boehringer Mannheim Gmbh Production and use of antibodies against collagen
DK0711415T3 (en) 1993-07-28 1999-04-26 Roche Diagnostics Gmbh Immunoassay for detection of collagen or collagen fragments
JPH08100000A (en) 1994-09-30 1996-04-16 Morinaga & Co Ltd Antibody against human iv type collagen and its utilization
US5763272A (en) 1994-12-23 1998-06-09 Boehringer Mannheim Gmbh Hybridoma for producing antibody for collagen I
JPH0921803A (en) * 1995-07-07 1997-01-21 Teijin Ltd 2 type collagen telopeptide measuring method
US6107047A (en) * 1996-03-21 2000-08-22 Osteometer Biotech A/S Assaying protein fragments in body fluids
JP3446493B2 (en) 1996-09-13 2003-09-16 トヨタ自動車株式会社 Exhaust manifold
ATE202632T1 (en) * 1996-12-09 2001-07-15 Osteometer Biotech As SANDWIGHT TEST FOR DETECTING COLLAGEN FRAGMENTS
GB9702252D0 (en) * 1997-02-06 1997-03-26 Univ Sheffield Medical The Sch Collagen assay

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014844A1 (en) * 1992-12-28 1994-07-07 Baylink David J Bone resorption assay
WO1995008115A1 (en) * 1993-09-17 1995-03-23 Osteometer Biotech As A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
WO1996012193A1 (en) * 1994-10-17 1996-04-25 Osteometer Bio Tech A/S Estimation of the fragmentation pattern of collagen in body fluids and the diagnosis of disorders associated with the metabolism of collagen
EP0718309A1 (en) * 1994-12-23 1996-06-26 Roche Diagnostics GmbH Antigens and antibodies for the detection of collagen I
WO1996030765A1 (en) * 1995-03-24 1996-10-03 Osteometer Biotech A/S Assaying protein fragments in body fluids
WO1996036645A1 (en) * 1995-05-19 1996-11-21 Washington Research Foundation Synthetic peptide analogs of cross-linked n-telopeptides of type i collagen
WO1998008098A2 (en) * 1996-08-22 1998-02-26 Osteometer Biotech A/S Assaying d-amino acids in body fluids
EP0829724A1 (en) * 1996-09-17 1998-03-18 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Assay for detecting collagen degradation

Also Published As

Publication number Publication date
JP2001506000A (en) 2001-05-08
WO1998026286A2 (en) 1998-06-18
DE69705423T2 (en) 2002-05-16
US20030148272A1 (en) 2003-08-07
JP3913787B2 (en) 2007-05-09
ATE202632T1 (en) 2001-07-15
ES2160985T3 (en) 2001-11-16
EP0944833B1 (en) 2001-06-27
AU5754298A (en) 1998-07-03
EP0944833A2 (en) 1999-09-29
DE69705423D1 (en) 2001-08-02
US6660481B2 (en) 2003-12-09
US7195883B2 (en) 2007-03-27
US20040224375A1 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
WO1998026286A3 (en) Sandwich assays for collagen type i fragments
AU5994194A (en) Method, test article, and system for performing assays
AU5665696A (en) Novel methods for the assay of troponin i and t and complexe s of troponin i and t and selection of antibodies for use in immunoassays
AU2172100A (en) Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids
AU3362097A (en) Method for antigen and antibody determination in bloodgroup serology
AU2468195A (en) Recombinant fibrin chains, fibrin and fibrin-homologs
AU5640694A (en) Reagent for endotoxin assay and method for endotoxin assay using the same
AU2358097A (en) Reinforced wood bat and method for making same
AU7422496A (en) NM03 antibody materials and methods
AU1774797A (en) Reactive dyes and lenses utilizing the same
EP0626450A3 (en) Ubiquitin conjugating enzyme (E2) fusion proteins.
AU3399295A (en) Method of detecting autoantibody present in the serum of reumatic
AU680166B2 (en) Hybrid composite articles and missile components, and their fabrication
AU1448295A (en) Assay employing both protein and antibody
AU7938294A (en) Method for controlled modification of enzymes, enzymes modified in this way and the use of such enzymes
AU6082394A (en) Thermostructural composite articles and method for making same
AU3472197A (en) Formable sandwich construction material and use of the material as construction material in vehicles, refrigerators, boats, etc.
AU1538497A (en) Anti-gp46 antibodies and fragments thereof and their use
GB2326712B (en) Colour devoloping method,enzyme immunoassay using the colour developing method,and immunochromatography incorporating the enzyme immunoassay
AU2547995A (en) Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
AU6117099A (en) Cardiac troponin i polypeptide fragments and uses in diagnostics
AU4356096A (en) Certifying system and transaction system with the certification
AU6483096A (en) Prenatal urinary screening for down syndrome and other aneupoidies
AU7436898A (en) Smart card with counter, in particular units or gratuities counter, and implementing method
EP0943684A3 (en) Frizzled-like polypeptides and polynucleotides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 526186

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 09319539

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 1997953745

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1997953745

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 1997953745

Country of ref document: EP